Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.

Area of Science:

• Biochemistry
• Molecular Biology
• Chemical Biology

Background:

• RNA-based gene silencing technologies like RNA interference (RNAi) and CRISPR-Cas9 are valuable tools.
• Chemical modification of RNA is crucial for developing in vivo therapeutics by improving stability, delivery, and specificity.
• While stability modifications are established, optimizing functional properties like cellular uptake and reducing off-target effects remains challenging.

Purpose of the Study:

• To synthesize and evaluate novel nonionic RNA analogues with amide linkages (AM1) replacing the phosphodiester backbone.
• To assess the potential of AM1 modifications to enhance RNA stability, specificity, and cellular uptake for RNA-based therapeutics.
• To investigate the impact of AM1 backbone replacement on the structure, stability, and biological activity of short interfering RNAs (siRNAs).

Main Methods:

• Synthesis of nonionic RNA analogues with amide linkages (AM1).
• Structural analysis using NMR and X-ray crystallography to determine AM1 mimicry of phosphodiester bonds.
• Functional assays to evaluate the biological activity, RNAi efficacy, and off-target effects of AM1-modified siRNAs.

Main Results:

• AM1 analogues effectively mimic phosphodiester linkages in RNA structure and thermal stability.
• Amide linkages are well-tolerated in siRNAs and can enhance RNAi activity.
• Specific AM1 modifications, particularly on the passenger strand, significantly reduced off-target activity while boosting desired RNAi effects.

Conclusions:

• Amide backbone modifications offer a promising strategy to improve the pharmacological properties of RNA therapeutics.
• AM1 linkages can enhance siRNA efficacy and specificity, addressing critical roadblocks for clinical applications.
• This work highlights the potential of amide linkages for optimizing functional RNAs in gene silencing and other biotechnologies.